CRON Q2 2022 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q2 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$28M+78.0% YoY

Gross Profit

$6M20.0% margin

Operating Income

-$33M-117.1% margin

Net Income

-$26M-93.6% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-2.0%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$19M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$61M

Stockholders' Equity

$1.7B

Cash & Equivalents

$1.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$16M	+78.0%
Gross Profit	$6M	-$16M	+135.2%
Operating Income	-$33M	-$60M	+45.9%
Net Income	-$26M	-$179M	+85.5%

Revenue Segments

Cannabis Flower

$16M68%

Cannabis Extracts

$7M31%

Product and Service, Other

$281,0001%

Geographic Segments

CANADA

$14M62%

ISRAEL

$7M31%

UNITED STATES

$1M6%